Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Marta Borghi

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection

Clinical Gastroenterology and Hepatology

Hepatology

Gastroenterology

2019

English

Related publications

Direct-Acting Antiviral Therapy for HCV Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

English

Increased Incidence or Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients Treated With Direct-Acting Antivirals: Myth or Fact?

Expert Review of Anticancer Therapy

Oncology

Pharmacology

2018

English

Imaging Findings of Hepatocellular Carcinoma That Developed After HCV Eradication With Direct-Acting Antivirals

Acta Hepatologica Japonica

Hepatology

2019

English

Hepatocellular Carcinoma Mechanisms Associated With Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment

Journal of Hepatocellular Carcinoma

2020

English

Infection Route of Hepatitis C Patients Treated With Direct-Acting Antivirals -To Evaluate the Risk of Reinfection-

Acta Hepatologica Japonica

Hepatology

2017

English

The Risk of Hepatocellular Carcinoma Is Increased in Hepatitis C Virus Patients Treated With Interferonfree Direct-Acting Antiviral-Based Therapy: True or False?

Biomedical Journal of Scientific & Technical Research

2018

English

Direct-Acting Antivirals and Recurrence of Hepatocellular Carcinoma

Liver Transplantation

English

Unexpected Viral Relapses in Hepatitis C Virus-Infected Patients Diagnosed With Hepatocellular Carcinoma During Treatment With Direct-Acting Antivirals

English

The Risk of Early Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C-Infected Patients Treated With Direct-Acting Antivirals With and Without Pegylated Interferon: A Belgian Experience

Journal of Viral Hepatitis

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Marta Borghi

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection

Related publications

Direct-Acting Antiviral Therapy for HCV Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

Increased Incidence or Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients Treated With Direct-Acting Antivirals: Myth or Fact?

Imaging Findings of Hepatocellular Carcinoma That Developed After HCV Eradication With Direct-Acting Antivirals

Hepatocellular Carcinoma Mechanisms Associated With Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment

Infection Route of Hepatitis C Patients Treated With Direct-Acting Antivirals -To Evaluate the Risk of Reinfection-

The Risk of Hepatocellular Carcinoma Is Increased in Hepatitis C Virus Patients Treated With Interferonfree Direct-Acting Antiviral-Based Therapy: True or False?

Direct-Acting Antivirals and Recurrence of Hepatocellular Carcinoma

Unexpected Viral Relapses in Hepatitis C Virus-Infected Patients Diagnosed With Hepatocellular Carcinoma During Treatment With Direct-Acting Antivirals

The Risk of Early Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C-Infected Patients Treated With Direct-Acting Antivirals With and Without Pegylated Interferon: A Belgian Experience